A

AFFiRiS AG

250 employees

AFFiRiS develops tailor-made peptide vaccines for alzheimer's, parkinson's, atheroclerosis, hypertension and several other conditions.

Basic info

biotechnology research

Biotechnology

Pharmaceutical

Parkinson’s disease

Immunotherapy

Multiple System Atrophy

Dementia with Lewy Bodies

Alzheimer’s disease

Medical

Neurodegenerative diseases

Huntington's Disease

2003

$34M

from 5 investors over 5 rounds

A

AFFiRiS AG raised $11M on April 25, 2017

Investors: MIG Capital

A

AFFiRiS AG raised $10M on June 28, 2016

Investors: Santoholding, MIG Capital and ARAX Capital Partners GmbH

A

AFFiRiS AG raised $34M on November 9, 2011

Investors: MIG Capital